Interleukin-1α -889 C/T polymorphism in Turkish patients with late-onset Alzheimer's disease

Dementia and Geriatric Cognitive Disorders

Volumn 27, Issue 1, 2009, Pages 82-87

  Dursun, Erdinç ^a   Gezen Ak, Duygu ^a   Ertan, Turan ^a   Bilgiç, Başar ^c   Gürvit, Hakan ^b   Emre, Murat ^b   Eker, Engin ^a   Engin, Funda ^a   Uysal, Ömer ^a   Yilmazer, Selma ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Istanbul Neuropsychiatry Hospital   (Turkey)

Author keywords

Alzheimer's disease; Brain aging; Inflammation; Interleukin 1 gene; Polymerase chain reaction with confronting two pair primers; Polymorphism

Indexed keywords

INTERLEUKIN 1ALPHA; DNA; PRIMER DNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC); ALLELE; GENETIC POLYMORPHISM; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; DNA; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INTERLEUKIN-1ALPHA; MALE; POLYMORPHISM, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TURKEY;

EID: 58249143940     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193627     Document Type: Article

References (49)

1. McGeer PL, McGeer EG: Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 2001;22:799-809.
2. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St. George Hyslop P, Selkoe DJ: Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 1997;3:67-72.
3. Grimaldi LM, Casadei VM, Ferri C, Veglia F, Licastro F, Annoni G, Biunno I, De Bellis G, Sorbi S, Mariani C, Canal N, Griffin WS, Franceschi M: Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 2000;47:361-365.
4. Hull M, Strauss S, Berger M, Volk M, Bauer J: Inflammatory mechanisms in Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1996;246:124-128.
5. Rothwell NJ, Luheshi GN: Interleukin I in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000;23:618-625.
6. Rubinsztein DC: The genetics of Alzheimer's disease. Prog Neurobiol 1997;52:447-454.
7. Du Y, Dodel RC, Eastwood BJ, Bales KR, Gao F, Lohmüller F, Müller U, Kurz A, Zimmer R, Evans RM, Hake A, Gasser T, Oertel WH, Griffin WS, Paul SM, Farlow MR: Association of an interleukin 1 α polymorphism with Alzheimer's disease. Neurology 2000;55:480-483.
8. Mrak RE, Griffin WS: Interleukin-1, neuroinflammation, and Alzheimer's disease. Neurobiol Aging 2001;22:903-908.
9. Bosco P, Guéant-Rodríguez RM, Anello G, Romano A, Namour B, Spada RS, Caraci F, Tringali G, Ferri R, Guéant JL: Association of IL-1 RN *2 allele and methionine synthase 2756 AA genotype with dementia severity of sporadic Alzheimer's disease. J Neurol Neurosurg Psychiatry 2004;75:1036-1038.
10. Combarros O, Sánchez-Guerra M, Infante J, Llorca J, Berciano J: Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease. J Neurol 2002;249:1242-1245.
11. Green EK, Harris JM, Lemmon H, Lambert JC, Chartier-Harlin MC, St. Clair D, Mann DM, Iwatsubo T, Lendon CL: Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD? Neurology 2002;58:1566-1568.
12. Hedley R, Hallmayer J, Groth DM, Brooks WS, Gandy SE, Martins RN: Association of interleukin-1 polymorphisms with Alzheimer's disease in Australia. Ann Neurol 2002;51:795-797.
13. Nicoll JA, Mrak RE, Graham DI, Stewart J, Wilcock G, MacGowan S, Esiri MM, Murray LS, Dewar D, Love S, Moss T, Griffin WS: Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 2000;47:365-368.
14. Seripa D, Matera MG, Dal Forno G, Gravina C, Masullo C, Daniele A, Binetti G, Bonvicini C, Squitti R, Palermo MT, Davis DG, Antuono P, Wekstein DR, Dobrina A, Gennarelli M, Fazio VM: Genotypes and haplotypes in the IL-1 gene cluster: analysis of two genetically and diagnostically distinct groups of Alzheimer patients. Neurobiol Aging 2005;26:455-464.
15. Rebeck GW: Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci Lett 2000;293:75-77.
16. Tsai SJ, Liu HC, Liu TY, Wang KY, Hong CJ: Lack of association between the interleukin-1 alpha gene C(-889)T polymorphism and Alzheimer's disease in a Chinese population. Neurosci Lett 2003;343:93-96.
17. Ki CS, Na DL, Kim DK, Kim HJ, Kim JW: Lack of association of the interleukin-1alpha gene polymorphism with Alzheimer's disease in a Korean population. Ann Neurol 2001;49:817-818.
18. Kölsch H, Ptok U, Bagli M, Papassotiropoulos A, Schmitz S, Barkow K, Kockler M, Rao ML, Maier W, Heun R: Gene polymorphisms of interleukin-1 alpha influence the course of Alzheimer's disease. Ann Neurol 2001;49:818-819.
19. Kuo YM, Liao PC, Lin C, Wu CW, Huang HM, Lin CC, Chuo LJ: Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia. Alzheimer Dis Assoc Dis 2003;17:94-97.
20. Li XQ, Zhang JW, Zhang ZX, Chen D, Qu QM: Interleukin-1 gene cluster polymorphisms and risk of Alzheimer's disease in Chinese Han population. J Neural Transm 2004;111:1183-1190.
21. Mattila KM, Rinne JO, Lehtimäki T, Röyttä M, Ahonen JP, Hurme M: Association of an interleukin 1B gene polymorphism (-511) with Parkinson's disease in Finnish patients. J Med Genet 2002;39:400-402.
22. Minster RL, DeKosky ST, Ganguli M, Belle S, Kamboh MI: Genetic association studies of interleukin-1 (IL-1A and IL-1B) and interleukin-1 receptor antagonist genes and the risk of Alzheimer's disease. Ann Neurol 2000;48:817-819.
23. Nishimura M, Sakamoto T, Kaji R, Kawakami H: Influence of polymorphisms in the genes for cytokines and glutathione S-transferase omega on sporadic Alzheimer's disease. Neurosci Lett 2004;368:140-143.
24. Pirskanen M, Hiltunen M, Mannermaa A, Iivonen S, Helisalmi S, Lehtovirta M, Koivisto AM, Laakso M, Soininen H, Alafuzoff I: Interleukin 1 alpha gene polymorphism as a susceptibility factor in Alzheimer's disease and its influence on the extent of histopathological hallmark lesions of Alzheimer's disease. Dement Geriatr Cogn Disord 2002;14:123-127.
25. Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nägga K, Bogdanovic N, Blennow K, Brookes AJ: Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 2001;9:437-444.
26. Wang HK, Hsu WC, Fung HC, Lin JC, Hsu HP, Wu YR, Hsu Y, Hu FJ, Lee-Chen GJ, Chen CM: Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia. Dement Geriatr Cogn Disord 2007;24:104-110.
27. Yucesoy B, Peila R, White LR, Wu KM, Johnson VJ, Kashon ML, Luster MI, Launer LJ: Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: The Honolulu-Asia Aging Study. Neurobiol Aging 2006;27:211-217.
28. Emahazion T, Feuk L, Jobs M, Sawyer SL, Fredman D, St. Clair D, Prince JA, Brookes AJ: SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet 2001;17:407-413.
29. Hamajima N, Saito T, Matsuo K, Kozaki K, Takahashi T, Tajima K: Polymerase chain reaction with confronting two-pair primers for polymorphism genotyping. Jpn J Cancer Res 2000;91:865-868.
30. Hamajima N: PCR-CTPP: a new genotyping technique in the era of genetic epidemiology. Expert Rev Mol Diagn 2001;1:119-123.
31. Matsuo K, Hamajima N, Suzuki R, Nakamura S, Seto M, Morishima Y, Tajima K: No substantial difference in genotype frequencies of interleukin and myeloperoxidase polymorphisms between malignant lymphoma patients and non-cancer controls. Hematologica 2001;86:602-608.
32. Hopkins SJ, Rothwell NJ: Cytokines and the nervous system. I. Expression and recognition. Trends Neurosci 1995;18:83-88.
33. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and Alzheimer's disease. Neurobiol Aging 2000;21:383-421.
34. Moore AH, O'Banion MK: Neuroinflammation and anti-inflammatory therapy for Alzheimer's disease. Adv Drug Deliv Rev 2002;54:1627-1656.
35. Wilson CJ, Finch CE, Cohen HJ: Cytokines and cognition - the case for a head-to-toe inflammation paradigm. J Am Geriatr Soc 2002;50:2041-2056.
36. Tuppo EE, Arias HR: The role of inflammation in Alzheimer's disease. Int J Biochem Cell Biol 2005;37:289-305.
37. McGeer PL, McGeer EG: Polymorphisms in inflammatory genes and the risk of Alzheimer disease. Arch Neurol 2001;58:1790-1792.
38. Fidani L, Goulas A, Mirtsou V, Petersen RC, Tangalos E, Crook R, Hardy J: Interleukin-1A polymorphism is not associated with late onset Alzheimer's disease. Neurosci Lett 2002;323:81-83.
39. Lee YB, Nagai A, Kim SU: Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 2002;69:94-103.
40. Griffin WS, Sheng JG, Roberts GW, Mrak RE: Interleukin-1 expression in different plaque types in Alzheimer disease: significance in plaque evolution. J Neuropathol Exp Neurol 1995;54:276-281.
41. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, White CL 3rd, Araoz C: Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Nat Acad Sci USA 1989;86:7611-7615.
42. Sheng JG, Mrak RE, Griffin WS: Glial-neuronal interactions in Alzheimer disease: progressive association of IL-1alpha+ microglia and S100beta+ astrocytes with neurofibrillary tangles stages. J Neuropathol Exp Neurol 1997;56:285-290.
43. Barger SW, Harmon AD: Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E. Nature 1997;388:878-881.
44. Mrak RE, Griffin WS: The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol Aging 2001;22:915-922.
45. Li Y, Barger SW, Liu L, Mrak RE, Griffin WS: S100β induction of the pro-inflammatory cytokine interleukin-6 in neurons: implications for Alzheimer pathogenesis. J Neurochem 2000;74:143-150.
46. Li R, Shen Y, Yang BL, Lue LF, Finch C, Rogers J: Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J Neurochem 2000;75:1447-1454.
47. Rogers J, Lue LF: Microglial chemotaxis, activation, and phagocytosis of amyloid β-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 2001;39:333-340.
48. Sciacca FL, Ferri C, Licastro F, Veglia F, Biunno I, Gavazzi A, Calabrese E, Martinelli Boneschi F, Sorbi S, Mariani C, Franceschi M, Grimaldi LM: Interleukin-1B polymorphism is associated with age at onset of Alzheimer's disease. Neurobiol Aging 2003;24:927-931.
49. Shibata N, Ohnuma T, Takahashi T, Baba, H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H: Effect of IL-6 polymorphism on risk of Alzheimer disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 2002;114:136-139.